安徽智飞龙科马生物制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
8
NMPA:8
Drug Approvals
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
- Product Name
- 四价流感病毒裂解疫苗
- Approval Number
- 国药准字S20250015
- Approval Date
- Mar 18, 2025
NMPA
Recombinant Mycobacterium Tuberculosis Fusion Protein(EC)
- Product Name
- 宜卡
- Approval Number
- 国药准字S20237004
- Approval Date
- Mar 13, 2023
NMPA
Recombinant COVID-19 Vaccine(CHO Cell)
- Product Name
- 智克威得
- Approval Number
- 国药准字S20220009
- Approval Date
- Feb 28, 2023
NMPA
Recombinant COVID-19 Vaccine(CHO Cell)
- Product Name
- 智克威得
- Approval Number
- 国药准字S20220010
- Approval Date
- Feb 28, 2023
NMPA
Mycobacterium vaccae for Injection
- Product Name
- 微卡
- Approval Number
- 国药准字S20010003
- Approval Date
- Jul 3, 2020
NMPA
Recombinant Mycobacterium Tuberculosis Fusion Protein(EC)
- Product Name
- 宜卡
- Approval Number
- 国药准字S20200006
- Approval Date
- Apr 23, 2020
NMPA
Recombinant Mycobacterium Tuberculosis Fusion Protein(EC)
- Product Name
- 宜卡
- Approval Number
- 国药准字S20200004
- Approval Date
- Apr 23, 2020
NMPA
Recombinant Mycobacterium Tuberculosis Fusion Protein(EC)
- Product Name
- 宜卡
- Approval Number
- 国药准字S20200005
- Approval Date
- Apr 23, 2020
NMPA
Clinical Trials
No trials found
News
No news found